Behavioral effects associated with chronic ketamine or remacemide exposure in rats

Neurotoxicology and Teratology

Volumn 29, Issue 3, 2007, Pages 348-359

  Wright, L K M ^a,b   Pearson, E C ^c   Hammond, T G ^c   Paule, M G ^a,b  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^b NATIONAL CENTER FOR TOXICOLOGICAL RESEARCH   (United States)

^c ASTRAZENECA   (United Kingdom)

Author keywords

Ketamine; N methyl d aspartate (NMDA) receptors; Operant behavior; Remacemide; Sodium channels

Indexed keywords

DIZOCILPINE; DOPAMINE 2 RECEPTOR; DOPAMINE TRANSPORTER; KETAMINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; REMACEMIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUDITORY DISCRIMINATION; BEHAVIOR CHANGE; BEHAVIOR DISORDER; CONTROLLED STUDY; DOSE RESPONSE; DRUG EXPOSURE; DRUG MECHANISM; FEMALE; LOW DRUG DOSE; NONHUMAN; PRIORITY JOURNAL; RAT;

ACETAMIDES; ACOUSTIC STIMULATION; ANIMALS; BEHAVIOR, ANIMAL; BODY WEIGHT; CONDITIONING, OPERANT; DISCRIMINATION (PSYCHOLOGY); DOSE-RESPONSE RELATIONSHIP, DRUG; EXCITATORY AMINO ACID ANTAGONISTS; FEMALE; KETAMINE; NEUROPROTECTIVE AGENTS; PHOTIC STIMULATION; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, N-METHYL-D-ASPARTATE; REINFORCEMENT SCHEDULE; SODIUM CHANNEL BLOCKERS;

RATTUS;

EID: 34249322691     PISSN: 08920362     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ntt.2006.12.004     Document Type: Article

References (29)

1. Auer R.N. Effects of age and sex on N-methyl-d-aspartate antagonist-induced neuronal necrosis in rats. Stroke 27 (1996) 743-746
2. Bourguignon J.P., Gerard A., Alvarez Gonzalez M.L., and Franchimont P. Neuroendocrine mechanism of onset of puberty: sequential reduction in activity of inhibitory and faciliatory N-methyl-d-aspartate receptors. J. Clin. Invest. 90 (1992) 1736-1744
3. Carlson N.R. Physiology of Behavior (1991), Allyn and Bacon, Boston, MA
4. Choi D.W. Glutamate neurotoxicity and diseases of the nervous system. Neuron 1 (1988) 623-634
5. Collingridge G.L., and Lester R.A.J. Excitatory amino acid receptors in the vertebrate central nervous system. Pharm. Rev. 40 (1989) 143-210
6. Ferguson S.A., and Paule M.G. Lack of effect of prefeeding on food-reinforced temporal response differentiation and progressive ratio responding. Behav. Processes 34 (1995) 153-160
7. Ferguson S.A., and Paule M.G. Progressive ratio performance varies with body weight in rats. Behav. Processes 40 (1997) 177-182
8. Haberny K.A., Paule M.G., Scallet A.C., Sistare F.D., Lester D.S., Hanig J.P., and Slikker Jr. W. Ontogeny of the N-methyl-d-aspartate (NMDA) receptor system and susceptibility to neurotoxicity. Toxicol. Sci. 68 (2002) 9-17
9. Haeseler G., Tetzlaff D., Bufler J., Dengler R., Munte S., Hecker H., and Leuwer M. Blockade of voltage-operated neuronal and skeletal muscle sodium channels by S(+)- and R(-)-ketamine. Anesth. Analg. 96 (2003) 1019-1026
10. Honack D., and Loscher W. Sex differences in NMDA receptor mediated responses in rats. Brain Res. 620 (1993) 167-170
11. Huang E.P., and Stevens C.F. The matter of mind: molecular control of memory. Essays Biochem. 33 (1998) 165-178
12. Hustveit O., Maurset A., and Oye I. Interaction of the chiral forms of ketamine with opioid, phencyclidine, sigma and muscarinic receptors. Pharmacol. Toxicol. 77 (1995) 355-359
13. Kapur S., and Seeman P. Ketamine has equal affinity for NMDA receptors and the high-affinity state of the dopamine D2 receptor. Biol. Psychiatry 49 (2001) 954-957
14. Liu L., Wong T.P., Pozza M.F., Lingenhoehl K., Wang Y., Sheng M., Auberson Y.P., and Wang Y.T. Role of NMDA receptor subtypes in governing the direction of hippocampal synaptic plasticity. Science 304 (2004) 1021-1024
15. Macdonald R.L., and Kelly K.M. Antiepileptic drug mechanisms of action. Epilepsia 36 (1995) S2-S12
16. Malek R., Borowicz K.K., Kimber-Trojnar Z., Sobeiszek G., Piskorska B., and Czuczwar S.J. Remacemide-a novel potential antiepileptic drug. Pol. J. Pharmacol. 55 (2003) 691-698
17. Nishimura M., Sato K., Okada T., Schloss P., Shimada S., and Tohyama M. MK-801 blocks monoamine transporters expressed in HEK cells. FEBS Lett. 423 (1998) 376-380
18. Nishimura M., Sato K., Okada T., Yoshiya I., Schloss P., Shimada S., and Tohyama M. Ketamine inhibits monoamine transporters expressed in human embryonic kidney 293 cells. Anesthesiology 88 (1998) 768-774
19. Palmer G.C. Neuroprotection by NMDA receptor antagonists in a variety of neuropathologies. Curr. Drug Targets 2 (2001) 241-271
20. Popke E.J., Allen R.R., Pearson E.C., Hammond T.G., and Paule M.G. Differential effects of two NMDA receptor antagonists on cognitive-behavioral development in nonhuman primates I. Neurotoxicol. Teratol. 23 (2001) 319-332
21. Popke E.J., Allen R.R., Pearson E.C., Hammond T.G., and Paule M.G. Differential effects of two NMDA receptor antagonists on cognitive-behavioral performance in young nonhuman primates II. Neurotoxicol. Teratol. 23 (2001) 333-347
22. Rocha B.A., Ward A.S., Egilmez Y., Lytle D.A., and Emmett-Oglesby M.W. Tolerance to the discriminative stimulus and reinforcing effects of ketamine. Behav. Pharmacol. 7 (1996) 160-168
23. Sakai F., and Amaha K. Midazolam and ketamine inhibit glutamate release via a cloned human brain glutamate transporter. Can. J. Anaesth. 47 (2000) 800-806
24. Seeman P., Ko F., and Tallerico T. Dopamine receptor contribution to the action of PCP, LSD and ketamine psychotomimetics. Mol. Psychiatry 10 (2005) 877-883
25. Smith D.J., Pekoe G.M., Martin L.L., and Coalgate B. The interaction of ketamine with the opiate receptor. Life Sci. 26 (1980) 789-795
26. Tilson H.A., and Mundy W.R. Basis of excitatory amino acid system-related neurotoxicity. In: Chang L.W., and Slikker Jr. W. (Eds). Neurotoxicology: Approaches and Methods (1995), Academic Press, San Diego, CA 359-370
27. Tomita J., Shibata Y., Sakurai T., and Okada Y. Involvement of a protein kinase C-dependent process in long-term potentiation formation in guinea pig superior colliculus slices. Brain Res. 536 (1990) 146-152
28. Tso M.M., Blatchford K.L., Callado L.F., McLaughlin D.P., and Stamford J.A. Stereoselective effects of ketamine on dopamine, serotonin and noradrenaline release and uptake in rat brain slices. Neurochem. Int. 44 (2004) 1-7
29. L.K.M. Wright, E.J. Popke, R.R. Allen, E.C. Pearson, T.G. Hammond, M.G. Paule, Effect of chronic MK-801 and/or phenytoin on the acquisition of complex behaviors in rats, Neurotoxicol Teratol, submitted for publication.